Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions.

Autor: Martins MB; Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil., de Assis Batista F; Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil., Marcello MA; Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil., Bufalo NE; Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil., Peres KC; Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil. Electronic address: karinacolombera@gmail.com., Morari EC; Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil; Department of Biological and Health Sciences, State University of Roraima, Boa Vista, Brazil., Soares FA; Department of General Pathology, Dental School, University of São Paulo, São Paulo, Brazil; Pathology Division, ID'Or Research Institute, Rede D'Or Hospitals Network, São Paulo, Brazil., Vassallo J; Laboratory Investigative and Molecular Pathology, CIPED, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil., Ward LS; Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences (FCM), University of Campinas (UNICAMP), Campinas, SP, Brazil.

Publikováno v: Annals of diagnostic pathology [Ann Diagn Pathol] 2021 Aug; Vol. 53, pp. 151766. Date of Electronic Publication: 2021 May 31.

Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases.

Autor: Kruithof PD; Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands., Lunev S; Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands., Aguilar Lozano SP; Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands., de Assis Batista F; Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands., Al-Dahmani ZM; Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands., Joles JA; University Medical Center Utrecht, Department of Nephrology and Hypertension, the Netherlands., Dolga AM; University of Groningen, Department of Pharmacy, Molecular Pharmacology, the Netherlands., Groves MR; Univeristy of Groningen, Department of Pharmacy and Drug Design, the Netherlands., van Goor H; University Medical Center Groningen, Department of Pathology and Medical Biology the Netherlands. Electronic address: h.van.goor@umcg.nl.

Publikováno v: Biochimica et biophysica acta. Molecular basis of disease [Biochim Biophys Acta Mol Basis Dis] 2020 Jun 01; Vol. 1866 (6), pp. 165716. Date of Electronic Publication: 2020 Feb 19.

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature.

Autor: Boonstra PA; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Hanzeplein, Groningen, The Netherlands., Gietema JA; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Hanzeplein, Groningen, The Netherlands., Suurmeijer AJH; University of Groningen, University Medical Center Groningen, Department of Pathology, Hanzeplein, Groningen, The Netherlands., Groves MR; University of Groningen, Faculty of Science and Engineering, Antonius Deusinglaan, Groningen, The Netherlands., de Assis Batista F; University of Groningen, Faculty of Science and Engineering, Antonius Deusinglaan, Groningen, The Netherlands., Schuuring E; University of Groningen, University Medical Center Groningen, Department of Pathology, Hanzeplein, Groningen, The Netherlands., Reyners AKL; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Hanzeplein, Groningen, The Netherlands.

Publikováno v: Oncotarget [Oncotarget] 2017 Nov 26; Vol. 8 (65), pp. 109836-109847. Date of Electronic Publication: 2017 Nov 26 (Print Publication: 2017).

Drug Target Validation Methods in Malaria - Protein Interference Assay (PIA) as a Tool for Highly Specific Drug Target Validation.

Autor: Meissner KA; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Saõ Paulo, Avenida Professor Lineu Prestes 1374, Saõ Paulo - SP 05508-000, Brazil., Lunev S; Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9700 AD, Groningen. Netherlands., Wang YZ; Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9700 AD, Groningen. Netherlands., Linzke M; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Saõ Paulo, Avenida Professor Lineu Prestes 1374, Saõ Paulo - SP 05508-000, Brazil., de Assis Batista F; Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9700 AD, Groningen. Netherlands., Wrenger C; Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Saõ Paulo, Avenida Professor Lineu Prestes 1374, Saõ Paulo - SP 05508-000, Brazil., Groves MR; Groningen Research Institute of Pharmacy, University of Groningen, Antonius Deusinglaan 1, 9700 AD, Groningen. Netherlands.

Publikováno v: Current drug targets [Curr Drug Targets] 2017; Vol. 18 (9), pp. 1069-1085.

Glutathione-Related Enzymes and Proteins: A Review.

Autor: Vašková, Janka¹ (AUTHOR) janka.vaskova@upjs.sk, Kočan, Ladislav² (AUTHOR), Vaško, Ladislav¹ (AUTHOR), Perjési, Pál³ (AUTHOR) janka.vaskova@upjs.sk

Publikováno v: Molecules. Feb2023, Vol. 28 Issue 3, p1447. 22p.